Vivos Therapeutics
VVOS
VVOS
30 hedge funds and large institutions have $1.38M invested in Vivos Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
51% less capital invested
Capital invested by funds: $2.82M → $1.38M (-$1.44M)
Holders
30
Holding in Top 10
–
Calls
$11K
Puts
–
Top Buyers
| 1 | +$34K | |
| 2 | +$27K | |
| 3 | +$26K | |
| 4 |
AF
Apexium Financial
Dallas,
Texas
|
+$26K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.6K |
Top Sellers
| 1 | -$131K | |
| 2 | -$70.3K | |
| 3 | -$29.7K | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$29.5K |
| 5 |
VF
Virtu Financial
New York
|
-$15K |